.gif "IP Gear")
- Joined
- Apr 9, 2021
- Messages
- 1,701
A Profile of MENT (Trestolone)
Author: Type-IIx
Personally, I believe MENT is a particularly suppressive compound comparable to testosterone+etonogestrel in its HPG axis suppression. It may provoke a significant rise in systolic blood pressure versus replacement T dosages [1]. However, I know it is gaining popularity quickly despite a paucity of evidence on tolerability, recovery of HPG axis function post-cycle, so as to make it difficult to make appropriate risk-balancing considerations. My personal belief is that you may want to steer clear of MENT, at least until more data is available, if you intend to cycle off (i.e., you do not intend to BnC forever).
Putting my personal view aside, here's my findings on MENT with literature and the detailed anecdotes of a veteran that I respect a great deal for his experience with AAS generally, and MENT in particular:
Trestolone; Methylnortestosterone; 7 alpha-methyl-19-nortestosterone
Non-5α-reducible; particularly estrogenic (aromatizes to 7α-ME), progestid
Ref. p. 347 (330) of Llewellyn
[Conservative] Dose: Under 10 mg daily - with an acetate ester, typically 10-20 mg e2-3d
Regarding potency, consider that cheque drops (mibolerone) is the 17α-methylated form of MENT.
7α-methylation
7α-methylation serves to increase the anabolic potency of MENT by:
- ↑AR affinity [2]
- ↓reduction of the delta-4 (Δ⁴) bond ∴ delta-5(10) isomers are the major excreted metabolites (hindering metabolic inactivation) [3]
- ↓affinity for SHBG binding [4]
Aromatization
MENT's aromatic product (7α-methylestradiol; 7α-ME) is more than 4x(!) as potent ("efficacious," a bad thing here) in ER-containing cells [5]. Efficacy is determined by measuring the effect, e.g., growth (here, in breast cancer cells). The EC₅₀ (EC50) is determined by the concentrations at which the ligand triggers growth (this may be confirmed by measurements of cell cycle progression (i.e., the S-phase entry during the cell cycle).
The binding affinity (IC₅₀) of MENT's aromatic product (7α-methylestradiol) is 102% that of estradiol [5] which is typically used as the reference compound for ER binding given its noteworthy efficacy, potency, and affinity for the ERα receptor, in the literature.
Given the findings of Attardi et al, in comparing the rate of aromatization between MENT and Nandrolone, that "At 180 min, about 23% of MENT was converted to 7α-ME and about 13% of 19-NT to E2," knowing that Nandrolone aromatizes at 20% the rate of T [6], we can deduce that MENT aromatizes at roughly 35% the rate of T... to 7α-ME (an aromatic product with four-fold E2's potency, i.e., for causing growth in breast cancer cells). Simple multiplication of the rate of aromatization (35%) * EC50(7α-methylestradiol) * RBA(7α-methylestradiol) ≈ a 40% greater growth potential in ER-containing cells than T.
This would seem to support the anecdotes that MENT is quite a potent gynecomastic agent. With consideration of practical use, if the MENT dosage is ~70% the Test dosage it's on par with the estrogenicity of T, and given the aromatization to 7α-ME rather than E2, this consequence is unlikely to be reflected in bloodwork results. By way of comparison, e.g.: 35mg daily of MENT E ≈ as estrogenic as 350mg of Test E weekly (sans data on metabolism).
And MENT does also has progestational activity to take into consideration.
SHBG
Despite MENT's lack of affinity for SHBG:
The dose-response relationship was not established between MENT and SHBG.
Another study [8] confirmed the SHBG reduction from MENT:
[4] shows MENT a weak SHBG ligand (virtually no binding to SHBG after acute administration)
Joints
Nothing quite provides the joint relief of nandrolone, however said joint relief can be achieved with just 150-200mgs ran along side any cycle. NPP being preferable for more mg per mg of actual compound but still. Do I note a subtle different in my knees when running just trestolone versus my baseline? Yeah but one tenth that of incorporating 200mgs of deca/npp.
However in the past running 100mg every day of ment ace, was comparable to 200-250mg of npp per day regarding performance metrics and lean tissue growth. Actually probably more likened to 150-200mg NPP ED run alongside Anadrol. You lack the aggression of tren, so you don’t have that “not heavy enough” attitude, but the weights you were moving will move a lot faster, and for more reps. You’re not going to tire out very quickly at all.
Ideally for your first ment cycle if you have joint issues, so long as you don’t have issues running 19nors, I would run 4 weeks at 25mg/day or 50mg/eod of ment, and at 3-4 weeks once you’ve seen how you’re going to react to ment add in 25mg/day or 50mg EOD of npp. Understand that both of these compound will compete at the receptor and testosterone will just be left to convert to estradiol or DHT. When running something like trestolone I find it but to run 100-150mg (TRT dose) of test along side but not more. If you have issues with 19 Nors, this drug will not be pleasant. This is the only drug that at high doses made me lactate and require prami.
Dosage
25mg per day or 50mg EOD to start. Twice weekly even for Trest E is too infrequent.
This dosage speculation [from Llewellyn] is largely based on the fact that a therapeutic replacement dose was less than 1mg per day, however in practice it really doesn't translate well. No, 1mg per day of testolone acetate is not going to replace a 100-200mg TRT dosage in the grand scheme of things. One of the primary factors in it being dropped was that at such a dosage there was insufficient estradiol conversion and activity at such dosages. While it is very anabolic, in terms of taking to improve performance metrics a higher dose is needed. Goals as well as experience and tolerability of a compound for you the individual come into play. Also keep in mind that just because at X dose its 10 fold stronger than testosterone, doesn't mean that at higher dosages that scales evenly. I would say 3:1 to 5:1 depending on how you respond once your in the 200-400mg range, not 10:1. The beauty of ment for me would be the mineral retention, and insanely rapid glycogen replenishment (diet supporting of course). I will tell you that running 700mg/week in the past that it was not equal to running 7 grams of test (10:1), nor 3500mg of test (5:1), but more like 2.5-3 grams at most.
Author: Type-IIx
Personally, I believe MENT is a particularly suppressive compound comparable to testosterone+etonogestrel in its HPG axis suppression. It may provoke a significant rise in systolic blood pressure versus replacement T dosages [1]. However, I know it is gaining popularity quickly despite a paucity of evidence on tolerability, recovery of HPG axis function post-cycle, so as to make it difficult to make appropriate risk-balancing considerations. My personal belief is that you may want to steer clear of MENT, at least until more data is available, if you intend to cycle off (i.e., you do not intend to BnC forever).
Putting my personal view aside, here's my findings on MENT with literature and the detailed anecdotes of a veteran that I respect a great deal for his experience with AAS generally, and MENT in particular:
Trestolone; Methylnortestosterone; 7 alpha-methyl-19-nortestosterone
Non-5α-reducible; particularly estrogenic (aromatizes to 7α-ME), progestid
Ref. p. 347 (330) of Llewellyn
[Conservative] Dose: Under 10 mg daily - with an acetate ester, typically 10-20 mg e2-3d
Regarding potency, consider that cheque drops (mibolerone) is the 17α-methylated form of MENT.
7α-methylation
7α-methylation serves to increase the anabolic potency of MENT by:
- ↑AR affinity [2]
- ↓reduction of the delta-4 (Δ⁴) bond ∴ delta-5(10) isomers are the major excreted metabolites (hindering metabolic inactivation) [3]
- ↓affinity for SHBG binding [4]
Aromatization
MENT's aromatic product (7α-methylestradiol; 7α-ME) is more than 4x(!) as potent ("efficacious," a bad thing here) in ER-containing cells [5]. Efficacy is determined by measuring the effect, e.g., growth (here, in breast cancer cells). The EC₅₀ (EC50) is determined by the concentrations at which the ligand triggers growth (this may be confirmed by measurements of cell cycle progression (i.e., the S-phase entry during the cell cycle).
The binding affinity (IC₅₀) of MENT's aromatic product (7α-methylestradiol) is 102% that of estradiol [5] which is typically used as the reference compound for ER binding given its noteworthy efficacy, potency, and affinity for the ERα receptor, in the literature.
Given the findings of Attardi et al, in comparing the rate of aromatization between MENT and Nandrolone, that "At 180 min, about 23% of MENT was converted to 7α-ME and about 13% of 19-NT to E2," knowing that Nandrolone aromatizes at 20% the rate of T [6], we can deduce that MENT aromatizes at roughly 35% the rate of T... to 7α-ME (an aromatic product with four-fold E2's potency, i.e., for causing growth in breast cancer cells). Simple multiplication of the rate of aromatization (35%) * EC50(7α-methylestradiol) * RBA(7α-methylestradiol) ≈ a 40% greater growth potential in ER-containing cells than T.
This would seem to support the anecdotes that MENT is quite a potent gynecomastic agent. With consideration of practical use, if the MENT dosage is ~70% the Test dosage it's on par with the estrogenicity of T, and given the aromatization to 7α-ME rather than E2, this consequence is unlikely to be reflected in bloodwork results. By way of comparison, e.g.: 35mg daily of MENT E ≈ as estrogenic as 350mg of Test E weekly (sans data on metabolism).
And MENT does also has progestational activity to take into consideration.
SHBG
Despite MENT's lack of affinity for SHBG:
[7]
The dose-response relationship was not established between MENT and SHBG.
Another study [8] confirmed the SHBG reduction from MENT:
[4] shows MENT a weak SHBG ligand (virtually no binding to SHBG after acute administration)
Joints
Nothing quite provides the joint relief of nandrolone, however said joint relief can be achieved with just 150-200mgs ran along side any cycle. NPP being preferable for more mg per mg of actual compound but still. Do I note a subtle different in my knees when running just trestolone versus my baseline? Yeah but one tenth that of incorporating 200mgs of deca/npp.
However in the past running 100mg every day of ment ace, was comparable to 200-250mg of npp per day regarding performance metrics and lean tissue growth. Actually probably more likened to 150-200mg NPP ED run alongside Anadrol. You lack the aggression of tren, so you don’t have that “not heavy enough” attitude, but the weights you were moving will move a lot faster, and for more reps. You’re not going to tire out very quickly at all.
Ideally for your first ment cycle if you have joint issues, so long as you don’t have issues running 19nors, I would run 4 weeks at 25mg/day or 50mg/eod of ment, and at 3-4 weeks once you’ve seen how you’re going to react to ment add in 25mg/day or 50mg EOD of npp. Understand that both of these compound will compete at the receptor and testosterone will just be left to convert to estradiol or DHT. When running something like trestolone I find it but to run 100-150mg (TRT dose) of test along side but not more. If you have issues with 19 Nors, this drug will not be pleasant. This is the only drug that at high doses made me lactate and require prami.
Dosage
25mg per day or 50mg EOD to start. Twice weekly even for Trest E is too infrequent.
This dosage speculation [from Llewellyn] is largely based on the fact that a therapeutic replacement dose was less than 1mg per day, however in practice it really doesn't translate well. No, 1mg per day of testolone acetate is not going to replace a 100-200mg TRT dosage in the grand scheme of things. One of the primary factors in it being dropped was that at such a dosage there was insufficient estradiol conversion and activity at such dosages. While it is very anabolic, in terms of taking to improve performance metrics a higher dose is needed. Goals as well as experience and tolerability of a compound for you the individual come into play. Also keep in mind that just because at X dose its 10 fold stronger than testosterone, doesn't mean that at higher dosages that scales evenly. I would say 3:1 to 5:1 depending on how you respond once your in the 200-400mg range, not 10:1. The beauty of ment for me would be the mineral retention, and insanely rapid glycogen replenishment (diet supporting of course). I will tell you that running 700mg/week in the past that it was not equal to running 7 grams of test (10:1), nor 3500mg of test (5:1), but more like 2.5-3 grams at most.
